- Previous Close
0.0000 - Open
0.0428 - Bid --
- Ask --
- Day's Range
0.0428 - 0.0428 - 52 Week Range
0.0002 - 0.0428 - Volume
550 - Avg. Volume
516 - Market Cap (intraday)
147,156 - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 14, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
0913693 B.C. Ltd., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy to treat chronic tendon injuries, androgenetic alopecia, and skin aging by restoring cellular function to rejuvenate aging or sun damaged skin, regrow hair, and repair tendons. The company's product candidates include RCH-01, a cell therapy for pattern baldness; RCS-01, a cell therapy for aging or sun damaged skin; and RCT-01, a cell therapy for tendon degeneration. It is also developing DermaPrecise, a dermal injection device. The company has a licensing and collaborative agreement with YOFOTO (China) Health Industry Co. Ltd. to develop and commercialize programs. The company was formerly known as RepliCel Life Sciences Inc. and changed its name to 0913693 B.C. Ltd. in March 2025. 0913693 B.C. Ltd. is based in Vancouver, Canada.
www.replicel.comRecent News: REPCF
View MorePerformance Overview: REPCF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: REPCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: REPCF
View MoreValuation Measures
Error in retrieving data
Financial Highlights
Profitability and Income Statement
Profit Margin
-27.50%
Return on Assets (ttm)
-103.50%
Return on Equity (ttm)
--
Revenue (ttm)
353.74k
Net Income Avi to Common (ttm)
-97.29k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.81k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-238.41k